/Lists

Biotech Investors & VC Firms in North America

1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.

Omega Funds
BostonSeed–Late Stage
21 people
Sanderling Ventures
San MateoSeed$50K – $1M
7 people
Elm Street Ventures
New HavenSeed–Series A$250K – $1M
15 people
Remiges Ventures, Inc.
SeattleSeed
21 people
First Bight Ventures
HoustonSeed–Series A$1M – $2M
22 people
Merck Global Health Innovation Fund
RahwaySeed–Growth$10M
10 people
O2h Ventures
CambridgeSeed–Series A
23 people
Astellas Venture Management LLC
South San FranciscoSeed–Series C$200K – $5M
10 people
Questa Capital
San FranciscoGrowth$15M – $40M
15 people
Taihill Venture
CambridgePre-Seed–Seed
11 people
Rothenberg Ventures
Palo AltoPre-Seed–Series A$500K – $10M
1 person
DCVC Bio
Palo AltoSeed–Growth
16 people
Qiming Venture Partners USA
CambridgeSeed–Series B
19 people
Asset Management Company
Menlo ParkSeed–Series A$500K – $2M
6 people
Plum Alley Investments
New YorkSeed–Series A$500K – $1.5M
15 people
Ontario Centre of Innovation
TorontoPre-Seed–Seed$500K
19 people
Deep Future
Seattle
3 people
Lifeforce Capital
Chevy ChaseSeed–Series C$500K – $5M
3 people
Transform Capital Management
San FranciscoSeed–Late Stage
15 people
The March Group
DavisSeries A
23 people
Kairos Venture Investments, Llc
Beverly HillsPre-Seed–Series A$150K – $20M
13 people
Ontario Centre of Innovation programs
TorontoPre-Seed–Seed$500K
19 people
Adverb Ventures
San FranciscoPre-Seed–Series A$500K – $5M
8 people
FAST — by GETTYLAB
San FranciscoPre-Seed–Seed$100K
1 person

Related lists

Data sourced from public filings and firms' own websites — see our methodology.